Press release
Insomnia Market to Reach USD 6.70 Bn by 2029, emerging at a CAGR of 4.2 percent and forecast 20223-2029
Insomnia Market
The Global Insomnia Market Report provides a comprehensive analysis of the insomnia market, covering market dynamics, segment analysis, regional insights, and competitive strategies of key players. The report aims to offer stakeholders a clear understanding of the industry's past, present, and future trends.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/37228
What are Insomnia Market Dynamics:
An increasing in the launch of new sleep-inducing drugs, devices, and treatments is anticipated to drive the insomnia market growth. For example, the Insomnia Clinic in Bloomsbury has developed a new treatment for insomnia. The clinical trials for the Insomnia showed positive results where 80% of the patients displayed remarkable improvements. Likewise, Eisai Inc has developed a drug called lemborexant (dual orexin receptor antagonist), adual orexin receptor antagonist that anticipated to be effective for the treatment of the older population with insomnia. Positive results and low price of devices are predictable to be the major factors promoting demand for devices.
Get Full Reports: https://www.maximizemarketresearch.com/market-report/insomnia-market/37228/
Insomnia Market Regional Insights:
Asia Pacific (excluding Japan): Presents significant growth opportunities driven by an increase in shift-related work leading to higher instances of sleep disorders. Indonesia, India, and China are projected to be key growth regions.
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/37228
What is Insomnia Market Segmentation:
by Treatment Type
Non-Pharmacological TreatmentPharmacological Treatment
Prescription Sleep Aids
Over-the-Counter Sleep Aids
by Therapy
Cognitive Behavioral Therapy for Isomnia Hypnotherapy Other Alternative Therapies
by Drug Class
Antidepressants Melatonin Antagonist Benzodiazepines Nonbenzodiazepines Orexin Antagonist Others
by Distribution Channel
Hospital Pharmacies Retail Pharmacies Drug Stores Online Pharmacies
Who are Insomnia Market Key Players:
1. Astellas
2. Biocodex S A
3. Consumer Healthcare Inc.
4. Dainippon Sumitomo
5. ECR Pharmaceuticals
6. Eisai Co.
7. Flynn Pharma
8. Johnson and Johnson
9. Meda Consumer Healthcare Inc.
10. Merck and Co. Inc.
11. Neurim
12. Pernix Therapeutics
13. Pfizer Inc
14. Purdue Pharma L.P.
15. Sanofi Pasteur
16. SkyePharma
17. Takeda Pharmaceutical Company
18. Mallinckrodt
19. Galt Pharmaceuticals, LLC.
20. Sumitomo Dainippon Pharma Co., Ltd.
21. Teva Pharmaceutical Industries Ltd.
22. Vanda Pharmaceuticals
Table of content for the Insomnia Market includes:
Insomnia Market: Research Methodology
Insomnia Market: Executive Summary
Market Overview and Definitions
Introduction to the Global Market
Summary
Key Findings
Recommendations for Investors
Recommendations for Market Leaders
Recommendations for New Market Entry
3.Insomnia Market: Competitive Analysis
MMR Competition Matrix
Market Structure by region
Competitive Benchmarking of Key Players
Consolidation in the Market
M&A by region
Key Developments by Companies
Market Drivers
Market Restraints
Market Opportunities
Market Challenges
Market Dynamics
PORTERS Five Forces Analysis
PESTLE
Regulatory Landscape by region
North America
Europe
Asia Pacific
Middle East and Africa
South America
COVID-19 Impact
Company Profile: Key players
Company Overview
Financial Overview
Global Presence
Capacity Portfolio
Business Strategy
Recent Developments
Request a Free Sample Copy or View Report Summary: https://www.maximizemarketresearch.com/request-sample/37228
More Related Reports:
Smoke Detector Market https://www.maximizemarketresearch.com/market-report/smoke-detector-market/14815/
Global Baby Food Market https://www.maximizemarketresearch.com/market-report/global-baby-food-market/24034/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Insomnia Market to Reach USD 6.70 Bn by 2029, emerging at a CAGR of 4.2 percent and forecast 20223-2029 here
News-ID: 3278244 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Po …
According to a new report by Maximize Market Research, the global power semiconductor market was valued at USD 41.63 billion in 2023 and is projected to reach USD 51.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.18% over the forecast period 2024-2030.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28191/
♦ Key Highlights
Market Size & CAGR: USD 41.63 Bn in 2023, expected to reach USD 51.83 Bn by…
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 …
According to a new report by Maximize Market Research, the global microneedle drug delivery systems market was valued at roughly US $ 6.11 billion in 2024 and is projected to reach approximately US $ 9.46 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.7%.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/215694/
♦ Key Highlights
Market size & CAGR: Estimated at ~US $ 6.11 billion in 2024, forecast to…
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CA …
According to a new report by Maximize Market Research, the global automotive paints market was valued at USD 10.85 billion in 2023 and is projected to reach USD 15.77 billion by 2030, growing at a CAGR of approximately 4.7 % during 2024-2030. The forecast covers global coatings used in vehicle manufacturing and refinish applications, with a focus on key regions such as Asia-Pacific, North America and Europe.
► Get a sample…
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5 …
According to a new report by Maximize Market Research, the global petrochemicals market was valued at USD 678.13 billion in 2024 and is projected to reach USD 1,122.31 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The growth is anchored in expanding demand across automotive, electronics, construction, and packaging industries.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/126575/
♦ Key Highlights
Market size + CAGR:…
More Releases for Insomnia
Emerging Insomnia Market Trends: Revolutionizing Insomnia Therapeutics With Inno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Insomnia Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the insomnia market has been on a constant rise. From $5 billion in 2024, the market is projected to expand to $5.24 billion in 2025, marking a compound annual growth rate…
Insomnia Treatment Market: Embrace Restful Nights and Recharge Your Life with Br …
Insomnia, a common sleep disorder, affects millions of people worldwide. The condition not only disrupts the sleep-wake cycle but also affects overall health and quality of life. With the increasing prevalence of insomnia, the demand for effective treatment options has surged, driving the growth of the insomnia treatment market.
Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to…
Insomnia - Drug Pipeline Landscape, 2023
Insomnia is a sleep disorder that is characterized by difficulty falling asleep or staying asleep. Insomnia can be caused by a variety of factors, including stress, anxiety, depression, medications, and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication.
There are two types of insomnia primary and secondary. Primary insomnia…
Insomnia - Drug Pipeline Landscape, 2022
Insomnia is a progressive, degenerative brain disorder that attacks the brain's nerve cells, or neurons, and causes them to waste away. This disease is characterized by a slow, gradual decline in memory, thinking, and reasoning skills. Alzheimer's is the most common form of dementia, accounting for 60 to 80 percent of all cases. Dementia is a general term for a decline in mental ability severe enough to interfere with daily…
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom.
The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning…
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account
The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases…
